Another study suggests that assays of GP73 achieve greater sensitivity and specificity than those for AFP, and GP73 serum levels increase with the malignant potential of liver diseases such as hepatitis, hepatic cirrhosis, and HCC [24]. Here, GOLM1 is linked to liver disorder.